市场调查报告书
商品编码
1586362
碳 13 市场、规模、占有率、趋势、行业分析报告:按纯度、按应用、按最终用户、按地区 - 市场预测,2024-2032 年Carbon-13 Market Size, Share, Trends, Industry Analysis Report: By Purity (98%-99% and >99%), Application, End User, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2024 - 2032 |
根据Polaris Market Research的最新研究,到2032年,全球碳13市场规模预计将达到1.2572亿美元。该研究报告提供了对当前市场动态的详细洞察,并对未来市场成长进行了分析。
碳 13 市场的主要驱动力是核磁共振 (NMR) 光谱的使用不断增加,这使得碳 13 对于分子结构的详细分析至关重要。 NMR 光谱依赖原子核的磁性,而碳 13 具有核自旋特性,在提供有关分子结构、动力学、反应状态和化学环境的详细资讯方面特别有用。
除了 NMR 光谱之外,医疗保健产业也是碳 13 的主要成长领域。这种同位素越来越多地用于非侵入性诊断程序,例如呼气测试,用于诊断各种胃肠道疾病,包括与消化性溃疡和胃癌相关的幽门螺旋桿菌(H. pylori)感染。
製造流程的技术进步预计将随着时间的推移降低成本,并使碳13更容易被更广泛的用户使用。同位素分离技术的创新和产能的扩大有可能缓解供应链限制并降低碳13的总成本。此外,不断壮大的中产阶级和不断上涨的医疗保健成本可能会推动对先进诊断工具的需求,包括那些利用碳13的诊断工具。
由于有机合成和材料科学领域的应用不断扩大,98%-99%的细分市场即使纯度稍低,也能提供令人满意的结果,在2023年占据市场主导地位。
由于医疗基础设施的扩张和成像能力的技术进步,磁振造影 (MRI) 领域预计将以最高的复合年增长率成长。此外,随着人口老化,慢性病的盛行率不断增加,也推动了对 MRI 等有效影像解决方案的需求。
由于先进研究机构和製药公司的存在,北美在 2023 年占据了碳 13 市场的主导地位。此外,由于对个人化医疗和先进诊断的日益重视,北美对碳 13 的需求正在增加。
由于人们更加关注快速工业化和医疗保健领域的进步,预计亚太市场未来几年将以高复合年增长率扩张。此外,旨在加强医疗基础设施的政府重大措施正在提振市场。
The global carbon-13 market size is expected to reach USD 125.72 million by 2032, according to a new study by Polaris Market Research. The report "Carbon-13 Market Size, Share, Trends, Industry Analysis Report: By Purity (98%-99% and >99%); Application; End-user; and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2024 - 2032." gives a detailed insight into current market dynamics and provides analysis on future market growth.
The primary driver of the carbon-13 market is the expanding use of nuclear magnetic resonance (NMR) spectroscopy, where Carbon-13 is essential for the detailed analysis of molecular structures. NMR spectroscopy relies on the magnetic properties of nuclei, and Carbon-13, with its nuclear spin properties, is particularly useful for providing detailed information about the structure, dynamics, reaction state, and chemical environment of molecules.
In addition to NMR spectroscopy, the healthcare sector is a major growth area for carbon-13. The isotope is increasingly used in non-invasive diagnostic procedures, such as breath tests, which are employed to diagnose various gastrointestinal disorders, including infections by Helicobacter pylori (H. pylori), which is linked to peptic ulcer disease and gastric cancer.
Technological advancements in production processes are expected to reduce costs over time, making carbon-13 more accessible to a broader range of users. Innovations in isotope separation techniques, as well as scaling up production capacities, may help alleviate some of the supply chain constraints and reduce the overall cost of carbon-13, thus expanding its market potential. Additionally, the expanding middle class and increasing healthcare spending are likely to boost the demand for advanced diagnostic tools, including those utilizing Carbon-13.
The 98%-99% segment dominated the market in 2023 due to the expansion of applications in organic synthesis and materials science, where slightly lower purity levels suffice while still providing satisfactory results.
The magnetic resonance imaging (MRI) segment is estimated to grow at the highest CAGR due to the expansion of healthcare infrastructure and technological advancements in imaging capabilities. Additionally, the rising prevalence of chronic diseases, alongside an aging population, significantly boosts the demand for effective imaging solutions such as MRI.
North America dominated the carbon-13 market in 2023 due to the presence of advanced research institutions and pharmaceutical companies. Furthermore, the increasing emphasis on personalized medicine and advanced diagnostics has bolstered demand for carbon-13 in North America.
The market in Asia Pacific is expected to expand at a high CAGR in the coming years owing to rapid industrialization and a growing emphasis on healthcare advancements. Additionally, significant government initiatives aimed at enhancing healthcare infrastructure are propelling the market.
The global key market players include China Isotope & Radiation Corporation, Merck KGaA, Shanghai Chemical Industry Research Institute Co., Ltd., Cambridge Isotope Laboratories, Inc., Trace Sciences International, ISOFLEX, MedChemExpress, BuyIsotope, Avanti Polar Lipids, and Qmx Laboratories Ltd.
Polaris Market Research has segmented the carbon-13 market report based on purity, application, end user, and region: